| Patent application number | Description | Published |
|---|
| 20090277502 | SOLAR CELL, SOLAR CELL MODULE USING THE SOLAR CELL AND METHOD FOR MANUFACTURING THE SOLAR CELL MODULE - In a solar cell, a body portion that includes at least one PN junction portion that is formed by laminating a P layer and an N layer in the front to back direction is formed. End faces of the PN junction portion form part of side faces of the body portion, and a surface electrode is formed on a surface of the body portion and a back surface electrode is formed on a back surface of the body portion. The surface electrode includes a terminal attachment portion to which a surface electrode connecting lead wire through which an electromotive force is extracted is bonded by wire-bonding or spot-welding. An anti-reflection film is formed on a surface of the surface electrode that includes the terminal attachment portion and the surface of the body portion other than a portion where the surface electrode is formed. | 11-12-2009 |
| 20090283127 | Method of Manufacturing Photoelectric Conversion Element and the Photoeletric Conversion Element - Disclosed is a method of manufacturing a photoelectric conversion element including a substrate and a stacked body configured of a plurality of compound semiconductor layers of different compositions sequentially stacked on the substrate, and having at least one pn junction in the stacked body. This method includes the steps of forming the stacked body configured of the plurality of compound semiconductor layers of different compositions sequentially stacked on the substrate; forming a protective film on the stacked body; forming a groove by removing at least a portion of the stacked body by at least one method selected from the group consisting of a mechanical removing method, dry etching and laser scribing; etching a side wall of the groove using an etching solution after forming the protective film and the groove; and cutting a portion corresponding to the groove for separation into a plurality of photoelectric conversion elements. Also disclosed is a photoelectric conversion element obtained by this method. | 11-19-2009 |
| 20110092524 | Agent for Enhancing Corneal Epithelial Barrier Function - The invention relates to a pharmacological action of a compound which functions as a PPARγ agonist on the barrier function of the corneal epithelium. A PPARγ agonist such as rivoglitazone, DRF-2593, GW-544 or BMS-298585 exhibits an excellent effect of enhancing the corneal epithelial barrier function in a test for enhancement of corneal epithelial barrier function, and therefore is useful as a preventive agent or a therapeutic agent for ocular infection or ocular unidentified complaint caused by a decrease in the corneal epithelial barrier function. Further, the PPARγ agonist can enhance the corneal epithelial barrier function of diabetic patients, patients with decreased corneal epithelial barrier function due to aging and patients who underwent refractive surgery such as PRK (photorefractive keratectomy) or LASIK (laser in situ keratomileusis) or cataract surgery. | 04-21-2011 |
| Patent application number | Description | Published |
|---|
| 20090205901 | SOUND ABSORBING STRUCTURE AND VEHICLE COMPONENT HAVING SOUND ABSORBING PROPERTY - A sound absorbing structure is constituted of a housing having a hollow portion and an opening and a vibration member composed of a board or diaphragm. The vibration member is a square-shaped material having elasticity composed of a synthetic resin and is bonded to the opening of the housing, thus forming an air layer closed inside the sound absorbing structure by the housing and the vibration member. In the sound absorbing structure, when the lateral/longitudinal dimensions of the air layer and characteristics of the vibration member (e.g. a Young's modulus, thickness, and Poisson's ratio) are set such that the fundamental frequency of a vibration occurring in a bending system falls within 5% and 65% of the resonance frequency of a spring-mass system, a vibration mode having a large amplitude occurs in a frequency band lower than the resonance frequency of the spring-mass system, this improving the sound absorption coefficient. | 08-20-2009 |
| 20090223738 | SOUND ABSORBING STRUCTURE AND VEHICLE COMPONENT HAVING SOUND ABSORPTION PROPERTY - A sound absorbing structure is constituted of a housing and a vibration member. The vibration member composed of a synthetic resin having elasticity is constituted of a first member and a second member whose surface density is smaller than the surface density of the first member, wherein the first member is fixed into a center hole of the second member so as to form a single board of the vibration member. Since the surface density of the center portion of the vibration member is higher than the surface density of the peripheral portion of the vibration member, the frequency of absorbed sound further decreases in comparison with the foregoing structure in which the vibration member is increased in weight to change the frequency of absorbed sound. This makes it possible to arbitrarily change the frequency of absorbed sound without substantially changing the overall weight of the sound absorbing structure. | 09-10-2009 |
| 20100089691 | SOUND ABSORBING STRUCTURE BUILT INTO LUGGAGE COMPARTMENT OF VEHICLE - A sound absorbing structure is constituted of a vibration plate and a rear air layer and is installed in a luggage compartment or trunk which is separated from a cabin in a vehicle. Sound waves entering into the luggage compartment drive the vibration plate to vibrate so that acoustic energy is converted into mechanical energy and is consumed by way of vibration of the vibration plate. By appropriately setting parameters and dimensions, the sound absorbing structure efficiently absorbs low-frequency sound such as road noise occurring due to friction of wheels of the vehicle traveling on a road. | 04-15-2010 |
| 20110056763 | ACOUSTIC RESONANCE DEVICE - An acoustic resonance device is installed in a compartment of a vehicle so as to reduce a low-frequency sound pressure (or noise) dependent upon a natural vibration. Specifically, an acoustic resonance device is a panel/diaphragm resonator, a resonance pipe, or a Helmholtz resonator, the inner space of which communicates with the compartment via an opening. The acoustic resonance device is positioned in proximity to an antinode of sound pressure owing to a natural vibration occurring in a driver/passenger space inside the compartment. Alternatively, the acoustic resonance device increases a particle velocity at a specific natural frequency or decreases sound pressure at an excitation frequency which occurs due to an external condition of the vehicle. The acoustic resonance device can be installed in a roof, a seat, a pillar supporting the roof, or a door of a vehicle. | 03-10-2011 |
| Patent application number | Description | Published |
|---|
| 20090105313 | Preventive or therapeutic agent for keratoconjunctival disorder - An object of the present invention is to provide a new medicinal use of 2-phenyl-1,2-benzisoselenazol-3(2H)-one or a salt thereof. 2-Phenyl-1,2-benzisoselenazol-3(2H)-one or a salt thereof exhibits an excellent prevention and improvement effect in corneal disorder models, and is therefore useful as a preventive or therapeutic agent for a keratoconjunctival disorder such as dry eye, superficial punctate keratopathy, corneal epithelial defects, corneal erosion, corneal ulcer, conjunctival epithelial defects, keratoconjunctivitis sicca, superior limbic keratoconjunctivitis, filamentary keratoconjunctivitis, keratitis or conjunctivitis. | 04-23-2009 |
| 20100120873 | PROPHYLACTIC OR THERAPEUTIC AGENT FOR AGE-RELATED MACULAR DEGENERATION - An object of the present invention is to find a novel medicinal use of 2-phenyl-1,2-benzisoselenazol-3(2H)-one or a salt thereof. 2-Phenyl-1,2-benzisoselenazol-3(2H)-one or a salt thereof exhibits an excellent inhibitory effect on neovascularization in the choroid and also has a protective effect on retinal pigment epithelial cell damage, and therefore is useful as a prophylactic or therapeutic agent for age-related macular degeneration. | 05-13-2010 |
